×

Back

Diabetes and CKD


Kidney Disease: Improving Global Outcomes (KDIGO) is a not-for-profit organization established to develop and implement global clinical practice guidelines for patients with kidney disease. Since its inception in 2003, KDIGO has published ten guidelines, beginning with the KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease (CKD). This proposed Scope of Work is designed to briefly describe the rationale for development of a guideline on the management of patients with diabetes and CKD and to outline the topics that this guideline intends to address.

 

We are now seeking public comments on the proposed Scope of Work presented here to ensure that feedback from all relevant stakeholders of this global guideline is duly considered before a formal systematic review of the literature is undertaken.

 

Please provide feedback via the comment form below by Wednesday, April 18.

 

>>> Click Here to Access the
Public Review Comment Form <<<


Downloads

Tools & Commentaries

Translations


DISCLAIMER: USE OF THE CLINICAL PRACTICE GUIDELINES

This Clinical Practice Guideline is based upon the best information available at the time of publication. The recommendations are designed to provide information and assist decision-making. They are not intended to define a standard of care, and should not be construed as one. Neither should they be interpreted as prescribing an exclusive course of management. Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every health care professional making use of this Guideline is responsible for evaluating the appropriateness of applying them in the setting of any particular clinical situation. The recommendations for research contained within this document are general and do not imply a specific protocol.